Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.

Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, Kristiansen PA, LaForce FM, Cohen T.

PLoS Med. 2018 Jan 24;15(1):e1002495. doi: 10.1371/journal.pmed.1002495. eCollection 2018 Jan.


Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Turner AEB, Gerson JE, So HY, Krasznai DJ, St Hilaire AJ, Gerson DF.

Synth Syst Biotechnol. 2017 Jan 20;2(1):49-58. doi: 10.1016/j.synbio.2016.12.002. eCollection 2017 Mar.


Parasite Carbohydrate Vaccines.

Jaurigue JA, Seeberger PH.

Front Cell Infect Microbiol. 2017 Jun 12;7:248. doi: 10.3389/fcimb.2017.00248. eCollection 2017. Review.


Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.

Liao G, Zhou Z, Suryawanshi S, Mondal MA, Guo Z.

ACS Cent Sci. 2016 Apr 27;2(4):210-8. doi: 10.1021/acscentsci.5b00364. Epub 2016 Apr 4.


Meningococcal Vaccinations.

Crum-Cianflone N, Sullivan E.

Infect Dis Ther. 2016 Jun;5(2):89-112. doi: 10.1007/s40121-016-0107-0. Epub 2016 Apr 16. Review.


Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.

Assaf-Casals A, Dbaibo G.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1825-37. doi: 10.1080/21645515.2016.1143157. Epub 2016 Feb 22. Review.


Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis.

Huttunen S, Toivanen M, Liu C, Tikkanen-Kaukanen C.

BMC Res Notes. 2016 Jan 13;9:25. doi: 10.1186/s13104-016-1838-4.


Vaccine-preventable infections in Systemic Lupus Erythematosus.

Murdaca G, Orsi A, Spanò F, Faccio V, Puppo F, Durando P, Icardi G, Ansaldi F.

Hum Vaccin Immunother. 2016 Mar 3;12(3):632-43. doi: 10.1080/21645515.2015.1107685. Review.


Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Liao G, Zhou Z, Guo Z.

Chem Commun (Camb). 2015 Jun 14;51(47):9647-50. doi: 10.1039/c5cc01794g.


Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.

Vasquez AE, Manzo RA, Soto DA, Barrientos MJ, Maldonado AE, Mosqueira M, Avila A, Touma J, Bruce E, Harris PR, Venegas A.

Hum Vaccin Immunother. 2015;11(3):776-88. doi: 10.1080/21645515.2015.1011011.


Epidemiological characteristics of meningococcal meningitis in the area of zenica-doboj canton in period from 2008 to 2012.

Alickovic I, Calkic L, Tandir S, Sivic S.

Med Arch. 2014 Jun;68(3):200-3. doi: 10.5455/medarh.2014.68.200-203. Epub 2014 May 31.


The biology of Neisseria adhesins.

Hung MC, Christodoulides M.

Biology (Basel). 2013 Jul 29;2(3):1054-109. doi: 10.3390/biology2031054.


Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease.

Hedari CP, Khinkarly RW, Dbaibo GS.

Infect Drug Resist. 2014 Apr 3;7:85-99. doi: 10.2147/IDR.S36243. eCollection 2014. Review.


Glycans in pathogenic bacteria--potential for targeted covalent therapeutics and imaging agents.

Tra VN, Dube DH.

Chem Commun (Camb). 2014 May 11;50(36):4659-73. doi: 10.1039/c4cc00660g. Review.


New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.

Panatto D, Amicizia D, Lai PL, Cristina ML, Domnich A, Gasparini R.

Indian J Med Res. 2013 Dec;138(6):835-46. Review.


Review of meningococcal vaccines with updates on immunization in adults.

Zahlanie YC, Hammadi MM, Ghanem ST, Dbaibo GS.

Hum Vaccin Immunother. 2014;10(4):995-1007. Epub 2014 Feb 5. Review.


Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.

van de Waterbeemd B, Zomer G, Kaaijk P, Ruiterkamp N, Wijffels RH, van den Dobbelsteen GP, van der Pol LA.

PLoS One. 2013 May 31;8(5):e65157. doi: 10.1371/journal.pone.0065157. Print 2013.


Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Anderson AS, Hao L, Jiang Q, Harris SL, Jones TR, Perez JL, York L, Eiden J, Jansen KU.

Hum Vaccin Immunother. 2013 Mar;9(3):471-9. Epub 2012 Dec 18.


Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Agier L, Deroubaix A, Martiny N, Yaka P, Djibo A, Broutin H.

J R Soc Interface. 2012 Dec 5;10(79):20120814. doi: 10.1098/rsif.2012.0814. Print 2013 Feb.


Prospects for eradication of meningococcal disease.

Nadel S.

Arch Dis Child. 2012 Nov;97(11):993-8. doi: 10.1136/archdischild-2012-302036. Epub 2012 Sep 15. Review.

Supplemental Content

Support Center